Biosim AI offers a comprehensive R&D platform and molecular simulation toolkit designed to enhance drug discovery and streamline computational analysis in life sciences. Their R&D platform integrates seamless data management, scalable processing, and AI-driven analysis, allowing researchers to centralize and standardize their data, capture experimental notes, and perform sophisticated analyses with the help of an AI analysis assistant. This platform supports interdisciplinary collaboration, enabling teams to document experiments, aggregate data, and visualize complex datasets efficiently. High-performance workstations are also available for intensive data processing, making it easier for organizations to achieve their research goals.

The molecular simulation toolkit provided by Biosim AI focuses on accelerating lead compound discovery through physicochemical simulations and AI. This toolkit allows researchers to screen billions of compounds for high-affinity leads, predict protein motions, and estimate binding affinities while assessing ADMET properties such as solubility and toxicity. With user-friendly interfaces like JupyterLab and VS Code, the toolkit is accessible via a cloud platform, facilitating rapid experimentation and analysis. Additionally, the Balto AI tool enhances the drug discovery process by simplifying data gathering, pocket finding, and small molecule docking through conversational AI, making advanced molecular modeling more accessible to researchers.

United States

We help scientists solve disease, develop drugs, and extend healthspan by building tools that simplify R&D, simulate biology, and untangle the complexity of life. Streamline computational analysis today. Discover drugs tomorrow.

Biosim AI

Company Details